RCKT
Rocket Pharmaceuticals Inc
2.60$
+2.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -62.5% | +275.6% | +18.3% | +65.0% | +29.1% | +168.8% | +369.3% | +16.6% | +13.3% | +32.1% | +17.6% | |
| – | -130.5% | – | +1,244.6% | +22.2% | +38.7% | +237.0% | -1.7% | +38.9% | +57.5% | +6.1% | +27.1% | +11.5% | -15.6% | |
| – | – | – | +3,845.9% | -93.7% | +61.4% | +175.4% | -3.9% | +237.5% | +0.1% | -30.5% | – | – | – | |
| – | – | -300.3% | – | +217.3% | -195.5% | – | -185.0% | – | -122.5% | – | +121.5% | -85.7% | -532.4% | |
| – | – | – | +0.0% | +18.2% | -85.6% | +1,975.7% | +1,501.4% | +24.9% | -73.5% | +11.7% | +91.1% | -64.4% | -92.5% | |
| – | – | – | +0.0% | +108.6% | – | -107.0% | +640.0% | +147.6% | – | -467.7% | +41.5% | – | -21.2% | |
| – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | +1,401,850.0% | -99.9% | -77.4% | -2,008.6% | – | -109.9% | – | -100.1% | -100.0% | – | – | |
| – | – | – | +2,285.5% | +264.8% | – | – | – | – | – | – | – | – | – | |
| – | +615.0% | -96.8% | +21,997.7% | -100.0% | +158,687.5% | +604,095.9% | +15.8% | +59.2% | -86.7% | +312.1% | +34.2% | -10.9% | -99.9% | |
| – | – | -180.3% | – | -165.7% | – | +93.0% | -21.5% | +50.8% | -157.8% | – | – | – | -179.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.